{
    "2018-07-03": [
        [
            {
                "time": "2018-07-03",
                "original_text": "机构资金流向每日分析:机构资金依然持续流出，中兴通讯首日出现机构大举买入",
                "features": {
                    "keywords": [
                        "机构资金",
                        "持续流出",
                        "中兴通讯",
                        "大举买入"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "通讯"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "资金流:科技3股超反3股流入居前 两市净流出28亿",
                "features": {
                    "keywords": [
                        "科技股",
                        "资金流入",
                        "净流出"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "上市公司药企全新市值排名！6家进入千亿俱乐部",
                "features": {
                    "keywords": [
                        "药企",
                        "市值排名",
                        "千亿俱乐部"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "国外药品加快落地中国市场，倒逼本土药企创新发展",
                "features": {
                    "keywords": [
                        "国外药品",
                        "中国市场",
                        "本土药企",
                        "创新发展"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "528亿资金争夺20股：主力资金重点出击10股(名单)",
                "features": {
                    "keywords": [
                        "资金争夺",
                        "主力资金",
                        "重点出击"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "[增持评级]医药生物行业周报：继续看好细分领域龙头 把握中报期的结构性机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "细分领域",
                        "龙头",
                        "中报期",
                        "结构性机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "MAH“一票”利好如何获得？深度分析相关政策与获批试点品种",
                "features": {
                    "keywords": [
                        "MAH",
                        "政策",
                        "获批试点品种"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "恒瑞医药大跌5.21%，报71.47元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "2018年7月医药行业投资策略：目前 对医药可以更乐观点",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资策略",
                        "乐观"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "医药生物：呼吸系统吸入制剂专题：呼吸科吸入制剂 下一个“胰岛素”行业",
                "features": {
                    "keywords": [
                        "医药生物",
                        "呼吸系统",
                        "吸入制剂",
                        "胰岛素"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}